Vasiliki Leventaki

Medicine & Life Sciences

1. Anaplastic Large-Cell Lymphoma 100%
2. Anaplastic Lymphoma Kinase 54%
3. Mantle-Cell Lymphoma 40%
4. Neoplasms 33%
5. STAT3 Transcription Factor 30%
6. Hodgkin Disease 29%
7. Apoptosis 26%
8. TOR Serine-Threonine Kinases 22%
9. Cell Cycle 20%
10. Lymphoma, Large B-Cell, Diffuse 19%
11. Cell Survival 18%
12. Phosphotransferases 18%
13. Transcription Factor AP-1 17%
14. Lymphoma 17%
15. Non-Hodgkin's Lymphoma 15%
16. Cell Line 15%
17. B-Cell Lymphoma 15%
18. nutlin 3 13%
19. Peripheral T-Cell Lymphoma 13%
20. Acute Myeloid Leukemia 12%
21. Inhibitor of Differentiation Protein 2 11%
22. Clone Cells 11%
23. Precursor Cell Lymphoblastic Leukemia-Lymphoma 11%
24. Serine 10%
25. Neurolymphomatosis 10%
26. Phosphorylation 10%
27. T-Cell Lymphoma 10%
28. Cell Cycle Checkpoints 10%
29. Eukaryotic Initiation Factor-4E 10%
30. Bone Marrow 10%
31. nucleophosmin 10%
32. Mutation 10%
33. fms-Like Tyrosine Kinase 3 10%
34. Proteins 9%
35. Burkitt Lymphoma 9%
36. Reed-Sternberg Cells 9%
37. Human Herpesvirus 4 9%
38. Fas-Associated Death Domain Protein 9%
39. Lymphoid Tissue 9%
40. Pediatrics 9%
41. Lymphocytes 9%
42. Cambodia 9%
43. Down-Regulation 9%
44. Primary Effusion Lymphoma 8%
45. G1 Phase Cell Cycle Checkpoints 8%
46. Cell Proliferation 8%
47. Myeloid Sarcoma 8%
48. Endodermal Sinus Tumor 8%
49. Tumor Cell Line 8%
50. Lymphoid Leukemia 8%